The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival in male breast cancer (MaBC) over the past three decades.
 
Jose Pablo Leone
Research Funding - Kazia Therapeutics (Inst)
 
Rachel A. Freedman
Research Funding - Eisai (Inst); Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Julieta Leone
No Relationships to Disclose
 
Michael J. Hassett
Research Funding - IBM
 
Sara M. Tolaney
Consulting or Advisory Role - Abbvie; AstraZeneca; Athenex; Bristol-Myers Squibb; Celldex; Certara Inc; CytomX Therapeutics; Daiichi Sankyo; Eisai; G1 Therapeutics; Genentech; Immunomedics/Gilead; Kyowa Hakko Kirin; Lilly; Merck; Mersana; NanoString Technologies; Nektar; Novartis; Odonate Therapeutics; OncoPep; Paxman; Pfizer; Puma Biotechnology; Samsung Bioepis; Sanofi; Seagen; Silverback Therapeutics
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cyclacel (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); NanoString Technologies (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Pfizer (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celldex; Eisai; Genentech/Roche; Immunomedics; Lilly; Merck; NanoString Technologies; Nektar; Novartis; Pfizer; Puma Biotechnology
 
Carlos Teodoro Vallejo
No Relationships to Disclose
 
Bernardo Amadeo Leone
No Relationships to Disclose
 
Eric P. Winer
Honoraria - Genentech/Roche; Genomic Health
Consulting or Advisory Role - Athenex; Carrick Therapeutics; G1 Therapeutics; Genentech/Roche; Gilead Sciences; GlaxoSmithKline; Jounce Therapeutics; Leap Therapeutics; Lilly; Seagen; Syros Pharmaceuticals; Zymeworks
Research Funding - Genentech (Inst)
Other Relationship - InfiniteMD
 
Nancy U. Lin
Consulting or Advisory Role - AstraZeneca; California Institute for Regenerative Medicine (CIRM); Daiichi Sankyo; Denali Therapeutics; Prelude Therapeutics; Prelude Therapeutics; Puma Biotechnology; Seagen
Research Funding - Genentech; Merck; Pfizer; Seagen
Patents, Royalties, Other Intellectual Property - Royalties for chapter in Up-to-Date regarding management of breast cancer brain metastases; Royalties, Jones & Bartlett